EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance

C Depner1, H Zum Buttel2, N Böğürcü1

  • 1Institute of Neuropathology, University of Giessen, Arndtstr. 16, D-35392 Giessen, Germany.

Nature Communications
|July 30, 2016
PubMed

Insights

Glioma invasion is promoted by downregulation of ephrinB2, a gene silenced by epigenetic changes and hypoxia-induced ZEB2. Targeting ZEB2 can inhibit glioma invasion and overcome resistance to anti-angiogenic therapies.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Cancer genetics

Background:

  • Diffuse invasion of brain parenchyma is a significant challenge in glioma treatment.
  • Anti-angiogenic agents face limitations due to tumor invasion and resistance mechanisms.

Purpose of the Study:

  • To identify key molecular mechanisms driving glioma invasion.
  • To investigate the role of ephrinB2 in glioma progression and therapeutic resistance.

Main Methods:

  • Analysis of ephrinB2 expression in human gliomas.
  • Genetic manipulation of ephrinB2 in a murine glioma model.
  • Investigation of hypoxia-inducible factor (HIF)-1α and ZEB2 involvement.
  • Assessment of ZEB2 inhibition in blocking tumor invasion.

Main Results:

  • EphrinB2 is downregulated in human gliomas via promoter hypermethylation and gene deletion.
  • Genetic deletion of ephrinB2 exacerbates invasion in a mouse glioma model.
  • Hypoxia-induced HIF-1α upregulates ZEB2, which represses ephrinB2 expression, enhancing invasiveness.
  • This mechanism is activated by anti-angiogenic treatment and blocked by ZEB2 inhibition.

Conclusions:

  • EphrinB2 downregulation is a critical step promoting glioma invasion.
  • ZEB2 acts as a key mediator of hypoxia-induced invasion and therapeutic resistance.
  • Targeting ZEB2 presents a promising strategy to inhibit glioma invasion and improve treatment outcomes.

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K